Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathwaysAhmed Awad, Manar A. Nader|Inflammopharmacology|2023Cited by 24